Challenges and Future Trends of Medical Devices in China
Release time:
2025-06-11
Author:
Source:
Abstract
While China's medical device industry is experiencing rapid market expansion, it still faces multiple challenges. Opportunities and pressures coexist, making it imperative to overcome difficulties and achieve breakthroughs. Looking to the future, the industry is accelerating its progress toward intelligence, green technology, and portability. This is not only a key path to breaking through bottlenecks and enhancing international competitiveness, but also a necessary choice in response to the "Healthy China 2030" initiative and the construction of a high-quality medical service system, heralding a new chapter of industrial upgrading and value creation.
Insufficient technological innovation capacity – a "bottleneck" pain point.
High-end medical imaging equipment (such as high-end CT, MRI, PET-CT), high-end reagents and equipment for in-vitro diagnostics, high-value consumables (such as cardiac intervention, neurointervention, ECMO), and core components of advanced treatment equipment (such as high-performance sensors, chips, and precision optical components) are heavily reliant on imports. There is a significant gap in R&D investment. Compared to international giants, domestic companies generally lack sufficient R&D investment intensity and sustainability, have weak basic research, and need to improve their original innovation capabilities. The transformation of research results is hindered. The synergy mechanism between industry, academia, research, and medicine is not smooth enough, and the efficiency of transforming laboratory results into industrialization and clinical applications is low, with significant obstacles in the "last mile".
Deepening of medical anti-corruption efforts
Purification of the circulation channels. Cracking down on kickbacks, commercial bribery, and other behaviors will, in the short term, affect the traditional marketing models and sales performance of some companies, causing pain. Restructuring value logic. In the long run, anti-corruption will force the industry to return to its essence of "clinical value as the core," compelling companies to invest more resources in genuine product innovation, quality improvement, and service optimization, rather than gray marketing. Squeeze effect and compliance costs. The survival space of non-compliant small and medium-sized enterprises will be compressed, and industry concentration may increase; at the same time, all enterprises face higher compliance requirements and costs.
Future Development Trends
Universally Accessible and Affordable
Green Materials Revolution
Material Recycling
Deep Empowerment by Artificial Intelligence
Digital and Intelligent Manufacturing
Precision Medicine
Recommended
Storage and transportation of disposable medical syringes
2025-07-07
My country's home medical device market is rising
2025-07-06
A disposable sterile infusion set is a common medical device
2025-07-05